NANOVATE
Live / Applied — Suspended — suspension letter mailed (as of 01 Oct 2025)
What this means for you
Not registered yet, but its 01 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99165346
- Mark type
- Stylized text
- Filed
- 01 May 2025
- Attorney of record
- Eric T. Fingerhut
Goods and services
- Class 005 — Pharmaceuticals: Biotechnological gene therapy, nucleic acid drug and protein delivery platform technology for loading, targeting, and enhancing secretomes, extracellular vesicles (EVs) and exosomes across gene therapy, RNA medicine, and protein therapeutics
- Class 042 — Scientific and technological services: Design, development and operation of gene therapy, nucleic acid drug and protein delivery platform technology for scientific and medical research and development to help pharmaceutical companies deliver proteins, antibodies, small molecule inhibitors, nucleic acid medicines, vaccines, gene silencing and gene editing
Owner
- Interactome Biotherapeutics Inc., Grand Rapids, MI, US
Prosecution history
- 01 Oct 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 01 Oct 2025 — LETTER OF SUSPENSION E-MAILED
- 01 Oct 2025 — SUSPENSION LETTER WRITTEN
- 19 Sept 2025 — ASSIGNED TO EXAMINER
- 10 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 May 2025 — APPLICATION FILING RECEIPT MAILED
- 01 May 2025 — NEW APPLICATION ENTERED